Molecular Formula | C22H19Cl3N8 |
Molar Mass | 501.8 |
Solubility | DMSO: ≥ 32 mg/mL |
Storage Condition | -20℃ |
In vitro study | CHIR-99021 inhibits human GSK-3β with K i values of 9.8 nM. CHIR-99021 is a small organic molecule that inhibits GSK3α and GSK3β by competing for their ATP-binding sites.In vitro kinase assays reveal that CHIR-99021 specifically inhibits GSK3β (IC 50 =~5 nM) and GSK3α (IC 50 =~10 nM), with little effect on other kinases. In the presence of CHIR-99021 the viability of the ES-D3 cells is reduced by 24.7% at 2.5 μM, 56.3% at 5 μM, 61.9% at 7.5 μM and 69.2% at 10 μM CHIR-99021 with an IC 50 of 4.9 μM. |
In vivo study | In ZDF rats, a single oral dose of CHIR-99021 (16 mg/kg or 48 mg/kg) rapidly lowers plasma glucose, with a maximal reduction of nearly 150 mg/dl 3-4 h after administration. CHIR99021 (2 mg/kg) given once, 4 h before irradiation, significantly improves survival after 14.5 Gy abdominal irradiation (ABI). CHIR99021 treatment significantly blocks crypt apoptosis and accumulation of p-H2AX + cells, and improves crypt regeneration and villus height. CHIR99021 treatment increases Lgr5 + cell survival by blocking apoptosis, and effectively prevents the reduction of Olfm4, Lgr5 and CD44 as early as 4 h. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.74 ml | 8.7 ml | 17.4 ml |
5 mM | 0.348 ml | 1.74 ml | 3.48 ml |
10 mM | 0.174 ml | 0.87 ml | 1.74 ml |
5 mM | 0.035 ml | 0.174 ml | 0.348 ml |
biological activity | CHIR-99021 trihydroxychloride (CT99021 trihydroxychloride) is a potent and selective GSK-3α/β inhibitor, the IC50 was 10 nM and 6.7 nM. CHIR-99021 trihydrochloride was more than 500-fold more selective for GSK-3 than CDC2,ERK2 and other protein kinases. CHIR-99021 trihydrochloride is also a potent activator of the Wnt/β-catenin signaling pathway. CHIR-99021 trihydrochloride enhances self-renewal of mouse and human embryonic stem cells. CHIR-99021 trihydrochloride can induce autophagy. |